Attenuation of amiodarone induced lung fibrosis and phospholipidosis in hamsters, by treatment with the platelet activating factor receptor antagonist, WEB 2086

Therapeutic use of amiodarone (AMD), a Class III antiarrhythmic drug is complicated by the development of lung fibrosis (LF) and phospholipidosis (PL). In the present study, the effectiveness of a PAF antagonist, WEB 2086, against AMD induced LF and PL has been tested in hamsters. The animals were r...

Descripción completa

Detalles Bibliográficos
Autores principales: Giri, S. N., Hyde, D. M., Haynam, D. R., Casias, M.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365411/
https://www.ncbi.nlm.nih.gov/pubmed/18475534
http://dx.doi.org/10.1155/S0962935193000389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365411/
https://www.ncbi.nlm.nih.gov/pubmed/18475534
http://dx.doi.org/10.1155/S0962935193000389

Ejemplares similares